ABC60+DTG5+3TC30mg disp.tab/PAC-90 NoCTN

General description:
Abacavir (as Sulfate) 60mg + Dolutegravir (as Sodium) 5mg and Lamivudine 30 mg dispersible tablets/ tablets for oral suspension in a fixed dose combination in a jar pack of 90 without outer carton, includes patient information leaflet.

Technical specification:
Each dispersible tablet/tablet for oral suspension contains Abacavir Sulfate equivalent to 60mg Abacavir plus Dolutegravir 5mg plus Lamivudine 30mg.
Package leaflet/ Patient Information Leaflet (PIL) affixed on bottle or included in shipper.

Therapeutic class:
Antiretroviral medicine

Shelf life:
24 months

Storage temperature instructions:
Do not store above 30°C

Material safety data sheet information (MSDS): No

Component of a KIT:
S9901049 - IEHK 2024,Suppl. PEP Unit

Guidelines for use:
https://www.who.int/teams/globa l-hiv-hepatitis-and-stis-programmes/guidelines/hiv-guidelines
WHO Paediatric ARV dosing dashboard - https://paedsarvdosing.org/